• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-383 通过靶向 LDHA 抑制卵巢癌细胞增殖、侵袭和有氧糖酵解。

miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.

出版信息

Neoplasma. 2017;64(2):244-252. doi: 10.4149/neo_2017_211.

DOI:10.4149/neo_2017_211
PMID:28043152
Abstract

MicroRNAs (miRNAs) are differentially expressed in various cancers and act as oncogenes or tumor suppressors. MiR-383 has been characterized as a cancer suppressor in several cancers. However, the exact expression patterns of miR-383 and the precise molecular mechanisms underlying its role in ovarian cancer have not been investigated thoroughly. In this study, we found that the expression of miR-383 was significantly downregulated in ovarian cancer tissues and ovarian cancer cell lines. Ectopic expression of miR-383 remarkably suppressed the ovarian cancer cell proliferation by enhancing cell apoptosis and significantly inhibited the invasion of ovarian cancer cells, while low expression of miR-383 exhibited the opposite effect. Bioinformatics analysis suggested LDHA as a novel target of miR-383, and miR-383 suppressed the expression level of LDHA mRNA by direct binding to its 3'-untranslated region (3'UTR). Expression of miR-383 was negatively correlated with LDHA in ovarian cancer tissues. In addition, modulation of miR-383 expression could affect the aerobic glycolysis in the ovarian cancer cells. Furthermore, Silencing of LDHA counteracted the effects of miR-383 suppression, while its overexpression reversed tumor inhibitory effects of miR-383. In conclusion, our study demonstrated that miR-383 regulated LDHA expression in ovarian cancer cells, thereby stunting glycolysis, cell proliferation and invasion.

摘要

微小 RNA(miRNA)在各种癌症中表达差异,作为癌基因或肿瘤抑制因子发挥作用。miR-383 已被确定为几种癌症中的肿瘤抑制因子。然而,miR-383 的确切表达模式及其在卵巢癌中作用的精确分子机制尚未得到充分研究。在这项研究中,我们发现 miR-383 在卵巢癌组织和卵巢癌细胞系中的表达明显下调。miR-383 的异位表达通过增强细胞凋亡显著抑制卵巢癌细胞的增殖,并显著抑制卵巢癌细胞的侵袭,而 miR-383 的低表达则表现出相反的效果。生物信息学分析表明 LDHA 是 miR-383 的一个新靶点,miR-383 通过直接结合其 3'非翻译区(3'UTR)抑制 LDHA mRNA 的表达水平。miR-383 在卵巢癌组织中的表达与 LDHA 呈负相关。此外,miR-383 表达的调节可以影响卵巢癌细胞中的有氧糖酵解。此外,沉默 LDHA 可以抵消 miR-383 抑制的作用,而过表达 LDHA 则可以逆转 miR-383 的肿瘤抑制作用。总之,我们的研究表明,miR-383 调节卵巢癌细胞中的 LDHA 表达,从而抑制糖酵解、细胞增殖和侵袭。

相似文献

1
miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.miR-383 通过靶向 LDHA 抑制卵巢癌细胞增殖、侵袭和有氧糖酵解。
Neoplasma. 2017;64(2):244-252. doi: 10.4149/neo_2017_211.
2
MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).微小RNA-33b通过靶向乳酸脱氢酶A(LDHA)抑制糖酵解来抑制骨肉瘤细胞增殖。
Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):31-35.
3
Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.受微小RNA负调控的乳酸脱氢酶A促进有氧糖酵解并在结直肠癌中升高。
Oncotarget. 2015 Aug 14;6(23):19456-68. doi: 10.18632/oncotarget.3318.
4
miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.miR-30a-5p 通过抑制 LDHA 介导的Warburg 效应抑制乳腺癌生长和转移。
Cancer Lett. 2017 Aug 1;400:89-98. doi: 10.1016/j.canlet.2017.04.034. Epub 2017 Apr 29.
5
MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA.miR-323a-3p 通过靶向 LDHA 抑制骨肉瘤的糖酵解。
Hum Cell. 2018 Oct;31(4):300-309. doi: 10.1007/s13577-018-0215-0. Epub 2018 Aug 7.
6
ANXA2P2/miR-9/LDHA axis regulates Warburg effect and affects glioblastoma proliferation and apoptosis.ANXA2P2/miR-9/LDHA 轴调节瓦博格效应,影响脑胶质瘤增殖和凋亡。
Cell Signal. 2020 Oct;74:109718. doi: 10.1016/j.cellsig.2020.109718. Epub 2020 Jul 21.
7
MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.微小RNA-34b-3和微小RNA-449a通过靶向乳酸脱氢酶A抑制鼻咽癌的恶性进展。
Oncotarget. 2016 Aug 23;7(34):54838-54851. doi: 10.18632/oncotarget.10761.
8
miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma.miR-200b是人类恶性胶质瘤中肿瘤进展和代谢的关键调节因子,其靶向乳酸脱氢酶A。
Oncotarget. 2016 Jul 26;7(30):48423-48431. doi: 10.18632/oncotarget.10301.
9
miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1.miR-9-5p 通过靶向 GOT1 抑制胰腺癌细胞增殖、侵袭和谷氨酰胺代谢。
Biochem Biophys Res Commun. 2019 Jan 29;509(1):241-248. doi: 10.1016/j.bbrc.2018.12.114. Epub 2018 Dec 24.
10
miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.微小RNA-142-3p通过靶向乳酸脱氢酶A抑制肝癌细胞的有氧糖酵解和细胞增殖。
Biochem Biophys Res Commun. 2018 Feb 12;496(3):947-954. doi: 10.1016/j.bbrc.2018.01.112.

引用本文的文献

1
Natural Metabolites as Modulators of Sensing and Signaling Mechanisms: Unlocking Anti-Ovarian Cancer Potential.天然代谢产物作为传感和信号传导机制的调节剂:挖掘抗卵巢癌潜力
Biomedicines. 2025 Jul 26;13(8):1830. doi: 10.3390/biomedicines13081830.
2
Development of a relapse-related RiskScore model to predict the drug sensitivity and prognosis for patients with ovarian cancer.开发一种与复发相关的风险评分模型,以预测卵巢癌患者的药物敏感性和预后。
PeerJ. 2025 Aug 11;13:e19764. doi: 10.7717/peerj.19764. eCollection 2025.
3
Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer.
蛋白磷酸酶2A癌性抑制剂(CIP2A)在卵巢癌中的新作用。
Sci Rep. 2025 Jul 1;15(1):22382. doi: 10.1038/s41598-025-05013-0.
4
Lactic acid metabolism: gynecological cancer's Achilles' heel.乳酸代谢:妇科癌症的致命弱点。
Discov Oncol. 2025 May 2;16(1):657. doi: 10.1007/s12672-025-02364-y.
5
Metabolomic Analysis of Histological Composition Variability of High-Grade Serous Ovarian Cancer Using H HR MAS NMR Spectroscopy.基于高分辨率魔角旋转核磁共振波谱的高级别浆液性卵巢癌组织学成分变异性的代谢组学分析。
Int J Mol Sci. 2024 Oct 10;25(20):10903. doi: 10.3390/ijms252010903.
6
Scutellarin Protects against Myocardial Ischemia-reperfusion Injury by Enhancing Aerobic Glycolysis through miR-34c-5p/ALDOA Axis.灯盏花素通过miR-34c-5p/醛缩酶A轴增强有氧糖酵解来预防心肌缺血再灌注损伤。
Int J Appl Basic Med Res. 2024 Apr-Jun;14(2):85-93. doi: 10.4103/ijabmr.ijabmr_415_23. Epub 2024 May 24.
7
Exploring the impact of circRNAs on cancer glycolysis: Insights into tumor progression and therapeutic strategies.探索环状RNA对癌症糖酵解的影响:对肿瘤进展和治疗策略的见解
Noncoding RNA Res. 2024 May 5;9(3):970-994. doi: 10.1016/j.ncrna.2024.05.001. eCollection 2024 Sep.
8
Glucose metabolism reprogramming in gynecologic malignant tumors.妇科恶性肿瘤中的葡萄糖代谢重编程
J Cancer. 2024 Mar 17;15(9):2627-2645. doi: 10.7150/jca.91131. eCollection 2024.
9
MiR-383 sensitizes osteosarcoma cells to bortezomib treatment via down-regulating PSMB5.miR-383 通过下调 PSMB5 使骨肉瘤细胞对硼替佐米治疗敏感。
Mol Biol Rep. 2024 Jan 22;51(1):170. doi: 10.1007/s11033-023-08964-7.
10
Research progress on the mechanism of glycolysis in ovarian cancer.卵巢癌糖酵解机制的研究进展。
Front Immunol. 2023 Nov 28;14:1284853. doi: 10.3389/fimmu.2023.1284853. eCollection 2023.